Abstract:AIM: To investigate the inhibitory effect of specialized human telomerase antisense oligodeoxyribonucleotides on the growth of well (MKN-28), moderately (SGC-7901) and poorly (MKN-45) differentiated gastric cancer cell lines under specific conditions and its inhibition mechanism, and to observe the correlation between the growth inhibition ratio and the tumor pathologic subtype of gastric cancer cells.METHODS: Telomerase activity in three gastric cancer cell lines of variant tumor pathologic subtype was determined by modified TRAP assay before and after the specialized human telomerase antisense oligodeoxyribonucleotides were dealt with under specific conditions. Effect of antisense oligomer under specific conditions of the growth and viability of gastric cancer cell lines was explored by using trypan blue dye exclusion assay, and cell apoptosis was detected by cell morphology observation, flow cytometry and TUNEL assay.RESULTS: Telomerase activity was detected in well, moderately and poorly differentiated gastric cancer cell lines (the quantification expression of telomerase activity was 43.7TPG, 56.5TPG, 76.7TPG, respectively). Telomerase activity was controlled to 30.2TPG, 36.3TPG and 35.2TPG for MKN-28, SGC-7901 and MKN-45 cell lines respectively after treatment with human telomerase antisense oligomers at the concentration of 5 mu mol/L, and was entirely inhibited at 10 mu mol/L, against the template region of telomerase RNA component, whereas no inhibition effect was detected in missense oligomers (P<0.05). After treatment with antisense oligomers at different concentrations under specific conditions for 96 h, significant growth inhibition effects were found in MKN-45 and SGC-7901 gastric cancer cell lines (the inhibition ratio was 40.89% and 71.28%), but not in MKN-28 cell lines (15.86%). The ratio of inactive SGC-7901 cells increased according to the prolongation of treatment from 48 to 96 h. Missense oligomers could not lead to the same effect (P<0.05). Apoptosis of SGC-7901 and MKN-45 cells was detected not only by morphology and TUNEL assay but also by flow cytometry. The apoptotic rate reached 33.56% for SGC-7901 cells and 44.75% for MKN-45 cells.CONCLUSION: The viability and proliferation of gastric cancer cells can be inhibited by antisense telomerase oligomers. The growth inhibition of gastric cancer cells is correlated with concentration, time and sequence specialty of antisense oligomers. The inhibition mechanism of antisense human telomerase oligomers depends not only on the sequence specialty but also on the biological characteristics of gastric cancer cell lines. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.

[Effects of Differentially Expressed Proteins in Hepatocellular Carcinoma Cell Treated by Different Telomerase Inhibitors].

Over-expression of LPTS-L in Hepatocellular Carcinoma Cell Line SMMC-7721 Induces Crisis

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

Proteomic Analysis of Human Bone Marrow Mesenchymal Stem Cells Transduced with Human Telomerase Reverse Transcriptase Gene During Proliferation

Profiling Protein Markers Associated with the Sensitivity to Concurrent Chemoradiotherapy in Human Cervical Carcinoma.

Comparative Proteomics Study on HepG2 Human Hepatocellular Carcinoma Cells and 7702 Human Normal Hepatocytes

Can Inhibition of Telomerase Increase Pancreatic Cancer Cell's Susceptibility to Chemotherapeutic Reagents?

Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers.

Inhibitory Effect Of Human Telomerase Antisense Oligodeoxyribonucleotides On The Growth Of Gastric Cancer Cell Lines In Variant Tumor Pathological Subtype

Analysis on Proteomic Profiling of Human Bone Marrow Mesenchymal Stem Cells Transduced with hTERT Gene

[The anti-cancer effect of siRNA targeting human telomerase reverse transcriptase in SMMC-7721 cells].

Stable Expression of Antisense Htr Inhibits in Vitro Pancreatic Cancer Cell Growth.

Nano-LC-MS/MS Based Proteomics of Hepatocellular Carcinoma Cells Compared to Chang Liver Cells and Tanshinone IIA Induction.

Screening of Key Molecules of HAb18G/CD147 Signal Transduction Pathway in Human Hepatoma Cells

Proteome Analysis of the Effects of Sorafenib on Human Hepatocellular Carcinoma Cell Line Hepg2

Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model

[Effect of Tanshinone II A on Expression of EGF and EGFR in Hepatocellular Carcinoma Cell Line SMMC-7721].

Inhibitory Effect of Sirna Targeted at Telomerase of Hepatocellular Carcinoma(hepg2)transfected by Lentivirus in Vitro

Screening of Serum Biomarkers Related to the Tumor Recurrence Following Liver Transplantation for Hepatocellular Carcinoma

Effects of chemotherapeutic drugs on telomer of human liver cancer BEL-7404 cell

THE EFFECTS OF DIFFERENT DRUGS ON TELOMERASE ACTIVITY OF LIVER CANCER BEL-7404 CELL